SAN DIEGO, June 15, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer ...
SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent Product Development Platform to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback